Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

447.52
Delayed Data
As of Apr 17
 -9.90 / -2.16%
Today’s Change
269.50
Today|||52-Week Range
495.50
+9.08%
Year-to-Date

Stock Price Forecast

The 23 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 455.00, with a high estimate of 560.00 and a low estimate of 375.00. The median estimate represents a +1.67% increase from the last price of 447.52.

Analyst Recommendations

The current consensus among 25 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.70
Sales
$824.7M
Reporting Date
Apr 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.15%
 
 
 
 
 
 
Growthannually 5.00%
 
 
 
 
 
 

Sales

Growthquarterly 2.79%
 
 
 
 
 
 
Growthannually 24.63%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account